comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 10:01:14 - browse：231

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How one medical school became remarkably diverse
Next article： Tome Biosciences co

hotspot

WSS

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Study gives hint on South Asians’ higher risk of cardiovascular disease

Flu vaccine offering decent levels of protection this winter, new data show

FDA does about

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

entertainment

comprehensive

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

BioMarin wins approval for gene therapy to treat hemophilia A

Having children helps parents live longer, especially after age 80

Novavax promises a turnaround & Lilly roils the obesity market

Kenai launches with $82 million for Parkinson’s stem cell therapy

Hepatitis C has a cure — but many Americans still lack access to it

How to address the problem of discarded donor organs

23andMe had bad news about my health. I wish a person had delivered it

Latigo launches with $135 million for Vertex

entertainment

House looks to weaken Medicare negotiation

FogPharma raises $145 million in rare Series E round

In search for therapies for solid tumors, companies turn to claudin

Readout Newsletter: Amylyx, Aurinia, and IQVIA

STAT Boddities: What happens to the brain when we get scared?

Juul documents reveal insider tactics on political lobbying

explore

hotspot

focus

explore